SCHMOUDER; Robert
Patent Applications and Registrations
Patent applications and USPTO patent grants for SCHMOUDER; Robert.The latest application filed is for "dosage regimen for a s1p receptor agonist".
- SCHMOUDER; Robert - Berkeley Heights NJ
| Patent | Date |
|---|---|
| Dosage Regimen For A S1p Receptor Agonist App 20220142949 - SCHMOUDER; Robert ; et al. | 2022-05-12 |
| Paediatric Compositions For Treating Multiple Sclerosis App 20210023027 - Kovarik; John M. ; et al. | 2021-01-28 |
| Dosage Regimen For A S1p Receptor Agonist App 20200330407 - SCHMOUDER; Robert ; et al. | 2020-10-22 |
| Dosage Regimen Of An S1p Receptor Modulator App 20200222338 - Boulton; Craig ; et al. | 2020-07-16 |
| Paediatric Compositions For Treating Multiple Sclerosis App 20200197334 - Kovarik; John M. ; et al. | 2020-06-25 |
| Dosage regimen of an S1P receptor modulator Grant 10,543,179 - Boulton , et al. Ja | 2020-01-28 |
| Paediatric Compositions For Treating Multiple Sclerosis App 20190358178 - Kovarik; John M. ; et al. | 2019-11-28 |
| Paediatric Compositions for Treating Multiple Sclerosis App 20190117593 - Kovarik; John ; et al. | 2019-04-25 |
| Dosage Regimen For A S1p Receptor Agonist App 20190091180 - SCHMOUDER; Robert ; et al. | 2019-03-28 |
| Dosage Regimen For A S1p Receptor Agonist App 20180289638 - Schmouder; Robert ; et al. | 2018-10-11 |
| Dosage Regimen Of An S1p Receptor Modulator App 20180263930 - Boulton; Craig ; et al. | 2018-09-20 |
| Dosage Regimen Of An S1p Receptor Modulator App 20180263929 - Boulton; Craig ; et al. | 2018-09-20 |
| Paediatric Compositions For Treating Multiple Sclerosis App 20180177747 - Kovarik; John M. ; et al. | 2018-06-28 |
| Paediatric Compositions For Treating Multiple Sclerosis App 20170333368 - Bastien; Marie-Claude ; et al. | 2017-11-23 |
| Dosage Regimen Of An S1p Receptor Modulator App 20170304226 - Boulton; Craig ; et al. | 2017-10-26 |
| Dosage Regimen For A S1p Receptor Agonist App 20170189353 - Schmouder; Robert ; et al. | 2017-07-06 |
| Paediatric Compositions For Treating Multiple Sclerosis App 20170128389 - Kovarik; John M. ; et al. | 2017-05-11 |
| Dosage Regimen For A S1p Receptor Agonist App 20160263061 - Schmouder; Robert ; et al. | 2016-09-15 |
| Dosage Regimen Of An S1p Receptor Modulator App 20160256416 - Boulton; Craig ; et al. | 2016-09-08 |
| Paediatric Compositions For Treating Multiple Sclerosis App 20160206574 - Kovarik; John M. ; et al. | 2016-07-21 |
| Dosage Regimen For A S1p Receptor Agonist App 20160081949 - SCHMOUDER; Robert ; et al. | 2016-03-24 |
| Paediatric Compositions For Treating Multiple Sclerosis App 20160022611 - Kovarik; John M. ; et al. | 2016-01-28 |
| Dosage Regimen Of An S1p Receptor Modulator App 20140187516 - BOULTON; Craig ; et al. | 2014-07-03 |
| Dosage Regimen For A S1p Receptor Agonist App 20140148415 - SCHMOUDER; Robert ; et al. | 2014-05-29 |
| Dosage Regimen For A S1p Receptor Agonist App 20140066657 - Schmouder; Robert ; et al. | 2014-03-06 |
| Paediatric Compositions For Treating Multiple Sclerosis App 20130230489 - Kovarik; John M. ; et al. | 2013-09-05 |
| Dosage Regimen Of An S1p Receptor Modulator App 20120264719 - Boulton; Craig ; et al. | 2012-10-18 |
| Dosage Regimen For A S1p Receptor Agonist App 20110257133 - Schmouder; Robert ; et al. | 2011-10-20 |
| Paediatric Compositions For Treating Multiple Sclerosis App 20110152380 - Kovarik; John M. ; et al. | 2011-06-23 |
| Dosage Regimen For A S1p Receptor Agonist App 20100160259 - Schmouder; Robert ; et al. | 2010-06-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 